What is the recommended treatment for adenomatoid tumors?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Adenomatoid Tumors

Simple surgical excision is the recommended treatment for adenomatoid tumors, as these are benign neoplasms with extremely low risk of recurrence or malignant transformation.

Characteristics of Adenomatoid Tumors

  • Adenomatoid tumors are rare benign neoplasms thought to be of mesothelial origin 1
  • They commonly occur in the reproductive organs of both males and females:
    • In females: uterus and fallopian tubes most commonly
    • In males: epididymis most commonly, but can also occur in spermatic cord, testicular tunica, and other sites 2, 3
  • Size typically ranges from 0.5 to 2.0 cm in greatest dimension 1
  • Often found incidentally during surgery or histopathological examination for other conditions
  • Frequently associated with uterine leiomyomas (56-80% of cases) 1

Treatment Approach

Primary Treatment

  • Simple excision of the tumor is the treatment of choice 1, 2
  • No need for extensive resection due to the benign nature of these tumors
  • For uterine adenomatoid tumors, enucleation can be performed if the uterus is not being removed for other reasons 1
  • Minimally invasive approaches (laparoscopy) have been successfully used for excision 4

Surgical Considerations

  • Conservative approach is recommended when these tumors are found in the epididymis 5
  • If found incidentally during surgery for other conditions (e.g., hysterectomy for leiomyomas), no additional specific treatment is needed
  • Frozen section analysis may be helpful if there is uncertainty about the diagnosis during surgery

Follow-up

  • Long-term follow-up of patients who have undergone surgery for adenomatoid tumors has never revealed recurrences, even over periods up to 22 years 1
  • "Malignant degeneration" is extremely rare 1
  • Routine intensive surveillance is not necessary given the benign nature of these tumors

Special Considerations

Differential Diagnosis

  • Important to distinguish from malignant tumors, particularly when located in the testis or epididymis
  • Histopathological examination is essential for definitive diagnosis
  • Typically shows proliferating glandular tissue covered with single-layered cells surrounded by proliferating smooth muscle cells 4

Coexisting Conditions

  • When adenomatoid tumors coexist with other conditions (e.g., leiomyomas, teratomas), treatment should address both conditions appropriately 4
  • The presence of an adenomatoid tumor does not alter the management approach for the coexisting condition

Conclusion

The management of adenomatoid tumors is straightforward due to their benign nature. Simple excision is curative, and the prognosis is excellent with virtually no risk of recurrence or malignant transformation. Minimally invasive surgical approaches can be considered when appropriate.

References

Research

Adenomatoid tumors of the uterus.

European journal of gynaecological oncology, 1990

Research

Tumors of the epididymis.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1977

Research

[Adenomatoid tumor of the epididymis. Report of a new case].

Archivos espanoles de urologia, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.